Advertisement
Canada markets open in 4 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7289
    -0.0009 (-0.12%)
     

  • CRUDE OIL

    82.27
    -0.54 (-0.65%)
     

  • Bitcoin CAD

    86,459.63
    -4,176.20 (-4.61%)
     

  • CMC Crypto 200

    1,345.24
    -37.33 (-2.70%)
     

  • GOLD FUTURES

    2,328.50
    -9.90 (-0.42%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.7140
    +0.0620 (+1.33%)
     

  • NASDAQ futures

    17,346.50
    -318.00 (-1.80%)
     

  • VOLATILITY

    16.87
    +0.90 (+5.64%)
     

  • FTSE

    8,056.75
    +16.37 (+0.20%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6818
    -0.0001 (-0.01%)
     
MARKETS LIVE BLOG:

STOCK FUTURES SLIDE AFTER META'S REALITY CHECK, WITH GDP ON DECK

Owner of Facebook and Instagram plans to spend up to US$10B on AI infrastructure investments

These 4 Psychedelic Biotech Stocks Are Leading the Pack

Alex Carchidi, The Motley Fool
·4 min read
These 4 Psychedelic Biotech Stocks Are Leading the Pack

Mental illnesses are tough to treat, and researchers are always looking for better ways to pull through for patients. In this vein, novel interventions based on the illicit psychedelic drugs of yesteryear could well become the advanced mental health therapies of tomorrow. Right now, there's a rapidly growing field of biotech companies developing treatments with psychedelics, and there's money to be made for investors who can identify the future winners.

Continue reading